Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

Indian Diabetes Market to Grow at 16.9% During 2018-2023

Copyright © IMARC. All Rights Reserved

About IMARC Group

Report Description

IMARC is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations.

Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description and Highlights

Report Description

Indian Diabetes Market to Grow at 16.9% During 2018-2023 The Indian diabetes market has experienced a robust growth over the past few years. This can be attributed to the growing awareness among consumers about the negative health effects of diabetes coupled with developing healthcare infrastructure in the country.

According to the latest report by IMARC Group, titled “Indian Diabetes Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, the Indian diabetes market reached a value of US$ 1,665 Million in 2017. Diabetes is a chronic disease caused by improper production of or response to insulin in the body which causes high blood sugar levels. Uncontrolled diabetes can result in a variety of complications, such as visual, cardiovascular, renal and neural disorders.

Report Description and Highlights

Report Description

The heightening obesity rates, rising stress levels and lack of proper exercise are the major causes of diabetes in India. In order to control the damage caused by the increasing cases of diabetes in the country, the Indian Government is taking initiatives to provide free treatment and insulin to diabetics at government hospitals.

The growing awareness among the consumers regarding the symptoms of diabetes and its adverse health effects have largely intensified the diagnosis and drug treatment rates in the country. This is the major growth-driving factor for the diabetes market in India. Some of the other factors contributing to the market growth are rapid urbanisation, developing healthcare infrastructure, low-cost of drug production, accelerating pharmaceutical contract manufacturing and introduction of advanced technologies. However, high research and development costs, stringent pricing policy, technological developments that make the existing drugs unmarketable or obsolete, and regulatory approvals in terms of quality control, price control and IPR (Intellectual Property Rights) protection are the major factors hampering the market growth.

Looking forward, the market value is projected to exceed US$ 4,261 Million by 2023, expanding at a CAGR of 16.9% during 2018-2023.

Read more here: https://www.imarcgroup.com/india-diabetes

Report Description and Highlights

Report Description Market Summary: • • • • •

On the basis of type, the market has been segmented into type-1 and type-2 diabetes. Currently, type-2 diabetes accounts for the maximum share.

On the basis of region, the market has been segregated into urban and rural regions. The prevalence of diabetes in the urban population is much higher as opposed to the rural areas.

Based on gender, the market has been classified into males and females. Amongst these, the prevalence of diabetes in males is higher in comparison with females.

On the basis of age group, age group of 40-59 years holds the largest share of the diabetes population in India. It is followed by age group of 60-79 years and 20-39 years.

The competitive landscape of the market has also been examined with some of the key players being Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon and Wockhardt.

Want more information about this market? Request a free report sample: https://www.imarcgroup.com/request?type=report&id=550&flag=B

Report Description and Highlights

Report Description Browse Related Report:

United States Diabetes Market Report: https://www.imarcgroup.com/us-diabetes-market Canada Diabetes Market Report: https://www.imarcgroup.com/canada-diabetes-market

Report Description and Highlights

Report Description

© 2017 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

Contact Us

FOR MORE DETAILS Visit us at :

https://www.imarcgroup.com Stay With Us:

TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com